Combination of Pertuzumab and Trastuzumab in the Treatment of HER2-Positive Early Breast Cancer: A Review of the Emerging Clinical Data
Megan Jagosky, Antoinette R Tan Department of Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute, Atrium Health, Charlotte, NC, USACorrespondence: Antoinette R TanLevine Cancer Institute, Atrium Health, 1021 Morehead Medical Drive, Charlotte, NC, 28204, USATel +1 980-442-...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2021-06-01
|
| Series: | Breast Cancer : Targets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/combination-of-pertuzumab-and-trastuzumab-in-the-treatment-of-her2-pos-peer-reviewed-fulltext-article-BCTT |